Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family
| Autor: | Eliezer Flescher, Dorit Reischer, Alina Heyfets, Natalia Goldin |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Programmed cell death
ATP synthase biology Physiology Cyclopentanes Cell Biology Oxidative phosphorylation Mitochondrion Antineoplastic Agents Phytogenic Oxidative Phosphorylation Mitochondria Cell biology Adenosine Triphosphate Biochemistry Apoptosis Neoplasms Cancer cell biology.protein Humans Cytotoxic T cell Glycolysis Oxylipins Tumor Suppressor Protein p53 Energy Metabolism |
| Zdroj: | Journal of Bioenergetics and Biomembranes. 39:51-57 |
| ISSN: | 1573-6881 0145-479X |
| DOI: | 10.1007/s10863-006-9061-y |
| Popis: | Jasmonates are plant stress hormones that induce suppression of proliferation and death in cancer cells, while being selectively inactive towards non-transformed cells. Jasmonates can overcome apoptotic blocks and exert cytotoxic effects on drug-resistant cells expressing p53 mutations. Jasmonates induce a rapid depletion of ATP in cancer cells. Indeed, this steep drop occurs when no signs of cell death are detectable yet. Experiments using modulators of ATP synthesis via glycolysis or oxidative phosphorylation suggest that the latter is the pathway suppressed by jasmonates. Consequently, the direct effects of jasmonates on mitochondria were evaluated. Jasmonates induced cytochrome c release and swelling in mitochondria isolated from cancer cells but not from normal ones. Thus, the selectivity of jasmonates against cancer cells is rooted at the mitochondrial level, and probably exploits differences between mitochondria from normal versus cancer cells. These findings position jasmonates as promising anti-cancer drugs acting via energetic depletion in neoplastic cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink